Lipella Pharmaceuticals Inc. (LIPO)

NASDAQ: LIPO · IEX Real-Time Price · USD

0.711

+0.007 (0.98%)

At close: Apr 26, 2024, 4:00 PM

0.709

-0.002 (-0.35%)

After-hours: Apr 26, 2024, 6:24 PM EDT

Lipella Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020
Net Income	-4.62	-2.6	-1.87	-0.06
Depreciation & Amortization	0	0	0	0
Share-Based Compensation	1.36	0.75	0.73	0.06
Other Operating Activities	0.11	0.02	0.15	-0.03
Operating Cash Flow	-3.15	-1.83	-0.99	-0.03
Capital Expenditures	-0.01	0	0	0
Change in Investments	0	0.3	-0.3	0
Investing Cash Flow	-0.01	0.3	-0.3	0
Share Issuance / Repurchase	0	4.96	2.1	0.55
Debt Issued / Paid	-0.28	0.28	0	0.06
Other Financing Activities	1.61	-	-	-
Financing Cash Flow	1.34	5.24	2.1	0.61
Net Cash Flow	-1.83	3.71	0.81	0.58
Free Cash Flow	-3.16	-1.83	-0.99	-0.03
Free Cash Flow Margin	-703.84%	-994.35%	-381.45%	-2.97%
Free Cash Flow Per Share	-0.53	-0.45	-0.29	-0.01

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).